IFN-γ selectively suppresses a subset of TLR4-activated genes and enhancers to potentiate macrophage activation.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
25 07 2019
Historique:
received: 26 09 2018
accepted: 25 06 2019
entrez: 27 7 2019
pubmed: 28 7 2019
medline: 18 12 2019
Statut: epublish

Résumé

Activation of macrophage proinflammatory and antimicrobial phenotypes is regulated by IFN-γ and LPS via synergistic induction of canonical, inflammatory NF-κB target genes. However, whether IFN-γ negatively regulates components of the LPS response, and how this may affect macrophage activation, is still unclear. Here we use combined transcriptomic and epigenomic approaches to find that IFN-γ selectively abrogates LPS-induced feedback and alters macrophage metabolic pathways by suppressing TLR4-mediated gene activation. In contrast to superinduction of inflammatory genes via enhancers that bind IRF1 and STAT1, IFN-γ represses target enhancers that bind STAT3. TLR4-activated but IFN-γ-suppressed enhancers comprise two subsets discernable by differential regulation of histone acetylation and recruitment of STAT3, CDK8 and cohesin. Our findings thus show that IFN-γ suppresses feedback inhibitory and metabolic components of TLR responses to enhance macrophage activation; they also provide insights for IFN-γ-mediated selective inhibition of TLR4-induced transcription. Such inhibition can contribute to severe and sustained inflammatory responses.

Identifiants

pubmed: 31346169
doi: 10.1038/s41467-019-11147-3
pii: 10.1038/s41467-019-11147-3
pmc: PMC6658531
doi:

Substances chimiques

Lipopolysaccharides 0
STAT1 Transcription Factor 0
STAT1 protein, human 0
STAT3 Transcription Factor 0
Toll-Like Receptor 4 0
Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3320

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI044938
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI046712
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR050401
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE019420
Pays : United States

Références

Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Trends Biochem Sci. 2014 Apr;39(4):170-82
pubmed: 24674738
Nat Biotechnol. 2010 May;28(5):511-5
pubmed: 20436464
Science. 2017 May 5;356(6337):513-519
pubmed: 28473584
Immunity. 2017 May 16;46(5):714-729
pubmed: 28514673
Nat Immunol. 2016 Jan;17(1):34-40
pubmed: 26681460
Blood. 2012 Mar 29;119(13):e110-9
pubmed: 22323479
J Leukoc Biol. 2007 Aug;82(2):237-43
pubmed: 17502339
Cell. 2014 Dec 4;159(6):1312-26
pubmed: 25480296
Arthritis Rheumatol. 2014 Jun;66(6):1583-95
pubmed: 24644022
Nat Rev Mol Cell Biol. 2015 Mar;16(3):155-66
pubmed: 25693131
Immunity. 2018 Jan 16;48(1):75-90.e6
pubmed: 29343442
Nat Immunol. 2015 Aug;16(8):838-849
pubmed: 26147685
Science. 2016 Apr 22;352(6284):aaf1098
pubmed: 27102489
Mol Cell. 2013 Aug 8;51(3):310-25
pubmed: 23932714
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
Nat Rev Genet. 2016 Apr;17(4):207-23
pubmed: 26948815
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Nature. 2010 Sep 23;467(7314):430-5
pubmed: 20720539
Nat Immunol. 2017 May;18(5):530-540
pubmed: 28288101
Science. 2015 Nov 20;350(6263):978-81
pubmed: 26516199
Nat Immunol. 2002 Apr;3(4):392-8
pubmed: 11896392
Nat Immunol. 2015 Jul;16(7):675-9
pubmed: 26086132
Nat Immunol. 2012 Oct;13(10):916-24
pubmed: 22990889
Nat Rev Immunol. 2011 Oct 25;11(11):750-61
pubmed: 22025054
Cell Rep. 2016 Sep 20;16(12):3121-3129
pubmed: 27653678
Science. 2013 Mar 22;339(6126):1448-53
pubmed: 23449998
Science. 2014 Sep 26;345(6204):1251086
pubmed: 25258085
Immunity. 2006 May;24(5):563-74
pubmed: 16713974
Immunity. 2017 Aug 15;47(2):235-250.e4
pubmed: 28813657
Cell. 2013 Jan 17;152(1-2):157-71
pubmed: 23332752
Nat Rev Immunol. 2010 May;10(5):365-76
pubmed: 20414208
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Immunity. 2013 Feb 21;38(2):250-62
pubmed: 23352233
Nat Methods. 2013 Dec;10(12):1213-8
pubmed: 24097267
Nat Immunol. 2018 Sep;19(9):932-941
pubmed: 30127433
J Immunol. 2012 Sep 15;189(6):2784-92
pubmed: 22904308
Trends Immunol. 2017 Jun;38(6):395-406
pubmed: 28396078
Immunity. 2013 Sep 19;39(3):454-69
pubmed: 24012417
Nat Immunol. 2016 Jan;17(1):26-33
pubmed: 26681459
Immunity. 2014 Jul 17;41(1):14-20
pubmed: 25035950
Immunity. 2014 Feb 20;40(2):274-88
pubmed: 24530056
Nat Rev Immunol. 2016 Sep;16(9):553-65
pubmed: 27396447
Immunity. 2009 Oct 16;31(4):539-50
pubmed: 19833085
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17609-14
pubmed: 23045702
Cell. 2017 Jan 12;168(1-2):135-149.e22
pubmed: 28086087
Cell Rep. 2015 Jul 14;12(2):300-12
pubmed: 26146080
Nat Rev Immunol. 2014 Jan;14(1):36-49
pubmed: 24362405
Cell. 2012 Nov 21;151(5):981-93
pubmed: 23178119
Cell. 2012 Jul 20;150(2):279-90
pubmed: 22817891
Nat Rev Immunol. 2018 Sep;18(9):545-558
pubmed: 29921905
J Exp Med. 2001 Oct 15;194(8):1123-40
pubmed: 11602641
Nat Immunol. 2016 Jan;17(1):18-25
pubmed: 26681458
Nat Immunol. 2017 Oct;18(10):1104-1116
pubmed: 28825701
Nat Rev Immunol. 2017 Oct;17(10):595-607
pubmed: 28580958
J Immunol. 2008 Oct 1;181(7):5089-97
pubmed: 18802113

Auteurs

Kyuho Kang (K)

Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 10021, USA. kangk@cbnu.ac.kr.
Department of Biology, Chungbuk National University, Cheongju, 28644, Republic of Korea. kangk@cbnu.ac.kr.

Mahesh Bachu (M)

Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 10021, USA.

Sung Ho Park (SH)

Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 10021, USA.

Keunsoo Kang (K)

Department of Microbiology, Dankook University, Cheonan, 31116, Republic of Korea.

Seyeon Bae (S)

Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 10021, USA.

Kyung-Hyun Park-Min (KH)

Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 10021, USA.

Lionel B Ivashkiv (LB)

Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 10021, USA. ivashkivl@hss.edu.
Graduate Program in Immunology and Microbial Pathogenesis, Weill Cornell Graduate School of Medical Sciences, New York, NY, 10021, USA. ivashkivl@hss.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH